|
Volumn 8, Issue 8, 2001, Pages 949-957
|
Design of NAALADase inhibitors: A novel neuroprotective strategy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (PHOSPHONOMETHYL)PENTANEDIOIC ACID;
ACIDIC DIPEPTIDASE INHIBITOR;
CARBOXYLIC ACID DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENZYME INHIBITOR;
GLUTAMIC ACID;
GLUTAMIC ACID DERIVATIVE;
GLUTARIC ACID DERIVATIVE;
MATRIX METALLOPROTEINASE;
METABOTROPIC RECEPTOR;
METABOTROPIC RECEPTOR AGONIST;
N ACETYLASPARTIC ACID;
N ACETYLASPARTYLGLUTAMIC ACID;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;
NEUROPEPTIDE;
PENTAFLUOROBENZYL PHOSPHINIC ACID;
PHOSPHINIC ACID DERIVATIVE;
PHOSPHORUS DERIVATIVE;
QUISQUALIC ACID;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BRAIN ISCHEMIA;
CHEMICAL STRUCTURE;
DRUG DESIGN;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
ENZYME INHIBITION;
HYDROLYSIS;
NERVE DEGENERATION;
NEUROLOGIC DISEASE;
NEUROPROTECTION;
NONHUMAN;
RAT;
STROKE;
|
EID: 0034934693
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867013372797 Document Type: Article |
Times cited : (75)
|
References (48)
|